Epoetin dosing and dialysis facility ownership.
Kliger
Alan S
AS
Nissenson
Allen R
AR
D000554:Ambulatory Care Facilities / Q000458:organization & administration*; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D004363:Drug Utilization / Q000706:statistics & numerical data; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D010067:Ownership; D010348:Patient Care Team; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects / Q000592:standards; D014481:United States
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa